ESTRO 2024 - Abstract Book

S1614

Clinical - Lung

ESTRO 2024

Conclusion:

HypoRT schemes for lung cancer can be relevant in selected cases. In our population, HypoRT provided adequate local control and had an excellent toxicity profile. Worse LC and OS than those described in literature is related to the heterogeneity and more advanced staging of our cohort. More mature OS data will follow with longer follow-up time.

Keywords: Lung, Hypofractionated Radiotherapy, Local Control

523

Digital Poster

Ensuring consistency in lung cancer radiotherapy quality in England using routinely collected data

Alexander P Kao 1 , Daniela Tataru 1 , Catherine Roe 1 , Petra Jankowska 2 , Fiona McDonald 3 , Michael Sharpe 1 , Ami Mehta 4 , Katie Spencer 1,5,6 1 NHS England, National Disease Registration Service, London, United Kingdom. 2 Somerset NHS Foundation Trust, Musgrove Park Hospital, Taunton, United Kingdom. 3 The Royal Marsden NHS Foundation Trusts, The Royal Marsden Hospital, London, United Kingdom. 4 NHS England, Cancer National Programme of Care, Specialised Commissioning, London, United Kingdom. 5 University of Leeds, Leeds Institute of Health Sciences, Leeds, United Kingdom. 6 Leeds Teaching Hospital NHS Trust, Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom

Purpose/Objective: